Skip to main content
logo
InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.290
-0.020 (-1.53%)
Sep 11, 2026, 4:00 PM EDT - Market closed

InMed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
6742310
Market Cap Growth
32.55%76.38%65.68%-23.21%-68.01%-62.35%
Enterprise Value
420-4-65
Last Close Price
1.291.553.255.3118.53235.20

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
--0.790.520.758.85
PB Ratio
6.416.440.290.260.261.06
P/TBV Ratio
5.366.440.330.320.301.38

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
--0.01--4.24

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
--0.060.110.030.09
Net Debt / Equity Ratio
-2.08-2.08-0.77-0.61-0.71-0.60
Net Debt / EBITDA Ratio
0.230.231.350.711.050.41
Net Debt / FCF Ratio
0.260.261.340.811.150.35
Asset Turnover
--0.360.360.310.10
Inventory Turnover
--2.942.441.33-
Quick Ratio
1.141.146.303.534.611.90
Current Ratio
1.371.376.994.415.662.89
Return on Equity (ROE)
-156.77%-156.77%-72.10%-72.08%-75.09%-226.07%
Return on Assets (ROA)
-66.46%-66.46%-36.12%-39.22%-38.94%-75.28%
Return on Capital Employed (ROCE)
-920.50%-920.50%-57.60%-82.60%-69.20%-143.60%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-210.61%-181.52%-208.04%-324.14%-257.74%-192.96%
FCF Yield
-150.08%-124.91%-197.97%-295.41%-241.44%-162.08%
Buyback Yield / Dilution
-326.64%-326.61%-156.13%-211.26%-336.59%-108.64%
SEC Filings: 10-K · 10-Q